Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-02-18 @ 1:37 AM
Study NCT ID:
NCT02503293
Status:
COMPLETED
Last Update Posted:
2019-04-09
First Post:
2015-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push
Sponsor:
Octapharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-29
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-11
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-01
First Submit QC Date:
None
Study First Post Date:
2015-07-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-05
Last Update Post Date:
2019-04-09
Last Update Post Date Type:
ACTUAL